References
- DennisLKDawsonDVMeta-analysis of measures of sexual activity and prostate cancerEpidemiology2002131727911805589
- DennisLKLynchCFTornerJCEpidemiologic association between prostatitis and prostate cancerUrology2002601788312100928
- RobertsROBergstralhEJBassSELieberMMJacobsenSJProstatitis as a risk factor for prostate cancerEpidemiology2004151939914712152
- MishinaTWatanabeHArakiHNakaoMEpidemiological study of prostatic cancer by matched-pair analysisProstate1985644234364088954
- PlatzEADe MarzoAMEpidemiology of inflammation and prostate cancerJ Urol20041712 Pt 2S36S4014713751
- PlatzEADe MarzoAMGiovannucciEProstate cancer association studies: pitfalls and solutions to cancer misclassification in the PSA eraJ Cell Biochem200491355357114755685
- PatelDABockCHSchwartzKWenzlaffASDemersRYSeversonRKSexually transmitted diseases and other urogenital conditions as risk factors for prostate cancer: a case – control study in Wayne County, MichiganCancer Causes Control200516326327315947878
- FernándezLGalánYJiménezRSexual behaviour, history of sexually transmitted diseases, and the risk of prostate cancer: a case-control study in CubaInt J Epidemiol200534119319715375086
- MaggioMBlackfordATaubDCirculating inflammatory cytokine expression in men with prostate cancer undergoing androgen deprivation therapyJ Androl200627672572816775253
- WiseGJMarellaVKTalluriGShirazianDCytokine variations in patients with hormone treated prostate cancerJ Urol20001643 Pt 172272510953133
- CoussensLMWerbZInflammation and cancerNature2002420691786086712490959
- De MarzoAMMarchiVLEpsteinJINelsonWGProliferative inflammatory atrophy of the prostate: implications for prostatic carcinogenesisAm J Pathol199915561985199210595928
- PutziMJDe MarzoAMMorphologic transitions between proliferative inflammatory atrophy and high-grade prostatic intraepithelial neoplasiaUrology200056582883211068311
- KhanNMukhtarHModulation of signaling pathways in prostate cancer by green tea polyphenolsBiochem Pharmacol201385566767223041649
- KatiyarSKPerezAMukhtarHGreen tea polyphenol treatment to human skin prevents formation of ultraviolet light B-induced pyrimidine dimers in DNAClin Cancer Res20006103864386911051231
- AhmadNGuptaSMukhtarHGreen tea polyphenol epigallocatechin-3-gallate differentially modulates nuclear factor kappaB in cancer cells versus normal cellsArch Biochem Biophys2000376233834610775421
- AhmadNFeyesDKNieminenALAgarwalRMukhtarHGreen tea constituent epigallocatechin-3-gallate and induction of apoptosis and cell cycle arrest in human carcinoma cellsJ Natl Cancer Inst19978924188118869414176
- ChenZPSchellJBHoCTChenKYGreen tea epigallocatechin gallate shows a pronounced growth inhibitory effect on cancerous cells but not on their normal counterpartsCancer Lett199812921731799719459
- OtsukaTOgoTEtoTAsanoYSuganumaMNihoYGrowth inhibition of leukemic cells by (-)-epigallocatechin gallate, the main constituent of green teaLife Sci19986316139714039952285
- YangGYLiaoJKimKYurkowEJYangCSInhibition of growth and induction of apoptosis in human cancer cell lines by tea polyphenolsCarcinogenesis19981946116169600345
- GuptaSAhmadNNieminenALMukhtarHGrowth inhibition, cell-cycle dysregulation, and induction of apoptosis by green tea constituent (−)-epigallocatechin-3-gallate in androgen-sensitive and androgen-insensitive human prostate carcinoma cellsToxicol Appl Pharmacol20001641829010739747
- GuptaSHastakKAhmadNLewinJSMukhtarHInhibition of prostate carcinogenesis in TRAMP mice by oral infusion of green tea polyphenolsProc Natl Acad Sci U S A20019818103501035511504910
- GuptaSHussainTMukhtarHMolecular pathway for (−)-epigallocatechin-3-gallate-induced cell cycle arrest and apoptosis of human prostate carcinoma cellsArch Biochem Biophys2003410117718512559991
- AgarwalRCell signaling and regulators of cell cycle as molecular targets for prostate cancer prevention by dietary agentsBiochem Pharmacol20006081051105911007941
- SiddiquiIAAdhamiVMAfaqFAhmadNMukhtarHModulation of phosphatidylinositol-3-kinase/protein kinase B- and mitogen-activated protein kinase-pathways by tea polyphenols in human prostate cancer cellsJ Cell Biochem200491223224214743383
- AdhamiVMSiddiquiIAAhmadNGuptaSMukhtarHOral consumption of green tea polyphenols inhibits insulin-like growth factor-I-induced signaling in an autochthonous mouse model of prostate cancerCancer Res200464238715872215574782
- HastakKGuptaSAhmadNAgarwalMKAgarwalMLMukhtarHRole of p53 and NF-kappaB in epigallocatechin-3-gallate-induced apoptosis of LnCap cellsOncogene200322314851485912894226
- ShimizuMDeguchiALimJTMoriwakiHKopelovichLWeinsteinIB(−)-Epigallocatechin gallate and polyphenon E inhibit growth and activation of the epidermal growth factor receptor and human epidermal growth factor receptor-2 signaling pathways in human colon cancer cellsClin Cancer Res20051172735274615814656
- JungYDKimMSShinBAEGCG, a major component of green tea, inhibits tumour growth by inhibiting VEGF induction in human colon carcinoma cellsBr J Cancer200184684485011259102
- SartippourMRShaoZMHeberDGreen tea inhibits vascular endothelial growth factor (VEGF) induction in human breast cancer cellsJ Nutr200213282307231112163680
- LeeYKBoneNDStregeAKShanafeltTDJelinekDFKayNEVEGF receptor phosphorylation status and apoptosis is modulated by a green tea component, epigallocatechin-3-gallate (EGCG), in B-cell chronic lymphocytic leukemiaBlood2004104378879414996703
- VayalilPKKatiyarSKTreatment of epigallocatechin-3-gallate inhibits matrix metalloproteinases-2 and -9 via inhibition of activation of mitogen-activated protein kinases, c-jun and NF-kappaB in human prostate carcinoma DU-145 cellsProstate2004591334214991864
- TakedaKAkiraSToll-like receptors in innate immunityInt Immunol200517111415585605
- TakedaKAkiraSRoles of Toll-like receptors in innate immune responsesGenes Cells20016973374211554921
- AkiraSMammalian Toll-like receptorsCurr Opin Immunol200315151112495726
- AkiraSTLR signalingCurr Top Microbiol Immunol200631111617048703
- HemmiHTakeuchiOKawaiTA Toll-like receptor recognizes bacterial DNANature2000408681374074511130078
- JakobTWalkerPSKriegAMUdeyMCVogelJCActivation of cutaneous dendritic cells by CpG-containing oligodeoxynucleotides: a role for dendritic cells in the augmentation of Th1 responses by immunostimulatory DNAJ Immunol19981616304230499743369
- KlinmanDMYiAKBeaucageSLConoverJKriegAMCpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gammaProc Natl Acad Sci U S A1996937287928838610135
- YiAKKlinmanDMMartinTLMatsonSKriegAMRapid immune activation by CpG motifs in bacterial DNA. Systemic induction of IL-6 transcription through an antioxidant-sensitive pathwayJ Immunol199615712539454028955187
- KriegAMYiAKMatsonSCpG motifs in bacterial DNA trigger direct B-cell activationNature199537465225465497700380
- HanagataNStructure-dependent immunostimulatory effect of CpG oligodeoxynucleotides and their delivery systemInt J Nanomedicine201272181219522619554
- JurkMVollmerJTherapeutic applications of synthetic CpG oligodeoxynucleotides as TLR9 agonists for immune modulationBioDrugs200721638740118020622
- SchmausserBAndrulisMEndrichSMuller-HermelinkHKEckMToll-like receptors TLR4, TLR5 and TLR9 on gastric carcinoma cells: an implication for interaction with Helicobacter pyloriInt J Med Microbiol2005295317918516044857
- RenTWenZKLiuZMLiangYJGuoZLXuLFunctional expression of TLR9 is associated to the metastatic potential of human lung cancer cell: functional active role of TLR9 on tumor metastasisCancer Biol Ther20076111704170917986857
- DiJMPangJPuXYToll-like receptor 9 agonists promote IL-8 and TGF-beta1 production via activation of nuclear factor kappaB in PC-3 cellsCancer Genet Cytogenet20091922606719596255
- MerrellMAIlvesaroJMLehtonenNToll-like receptor 9 agonists promote cellular invasion by increasing matrix metalloproteinase activityMol Cancer Res20064743744716849519
- IlvesaroJMMerrellMASwainTMToll like receptor-9 agonists stimulate prostate cancer invasion in vitroProstate200767777478117373717
- LeeSHongJChoiSYCpG oligodeoxynucleotides induce expression of proinflammatory cytokines and chemokines in astrocytes: the role of c-Jun N-terminal kinase in CpG ODN-mediated NF-kappaB activationJ Neuroimmunol20041531–2506315265663
- KunduSDLeeCBillipsBKThe toll-like receptor pathway: a novel mechanism of infection-induced carcinogenesis of prostate epithelial cellsProstate200868222322918092352
- DiJMPangJSunQPToll-like receptor 9 agonists up-regulates the expression of cyclooxygenase-2 via activation of NF-kappaB in prostate cancer cellsMol Biol Rep20103741849185519618291
- LinAKarinMNF-kappaB in cancer: a marked targetSemin Cancer Biol200313210711412654254
- KarinMLinANF-kappaB at the crossroads of life and deathNat Immunol20023322122711875461
- KarinMCaoYGretenFRLiZWNF-kappaB in cancer: from innocent bystander to major culpritNat Rev Cancer20022430131012001991
- GuptaSHastakKAfaqFAhmadNMukhtarHEssential role of caspases in epigallocatechin-3-gallate-mediated inhibition of nuclear factor kappa B and induction of apoptosisOncogene200423142507252214676829
- QinJWangYBaiYEpigallocatechin-3-gallate inhibits bladder cancer cell invasion via suppression of NF-kappaB–mediated matrix metalloproteinase-9 expressionMol Med Rep2012651040104422941057
- Rieger-ChristKMHanleyRLodowskyCThe green tea compound, (−)-epigallocatechin-3-gallate downregulates N-cadherin and suppresses migration of bladder carcinoma cellsJ Cell Biochem2007102237738817348027
- ShankarSGanapathySHingoraniSRSrivastavaRKEGCG inhibits growth, invasion, angiogenesis and metastasis of pancreatic cancerFront Biosci20081344045217981559
- BohleBJahn-SchmidBMaurerDKraftDEbnerCOligodeoxynucleotides containing CpG motifs induce IL-12, IL-18 and IFN-gamma production in cells from allergic individuals and inhibit IgE synthesis in vitroEur J Immunol19992972344235310427997
- AkhtarMWatsonJLNazliAMcKayDMBacterial DNA evokes epithelial IL-8 production by a MAPK-dependent, NF-kappaB-independent pathwayFASEB J200317101319132112832293
- QiaoBLiBYangXSpecific siRNA downregulated TLR9 and altered cytokine expression pattern in macrophage after CpG DNA stimulationCell Mol Immunol20052213013516191419
- InoueKSlatonJWEveBYInterleukin 8 expression regulates tumorigenicity and metastases in androgen-independent prostate cancerClin Cancer Res2000652104211910815938
- MooreBBArenbergDAStoyKDistinct CXC chemokines mediate tumorigenicity of prostate cancer cellsAm J Pathol199915451503151210329603
- Codony-ServatJMarin-AguileraMVisaLNuclear factor-kappa B and interleukin-6 related docetaxel resistance in castration-resistant prostate cancerProstate201373551252123038213
- MalinowskaKNeuwirtHCavarrettaITInterleukin-6 stimulation of growth of prostate cancer in vitro and in vivo through activation of the androgen receptorEndocr Relat Cancer200916115516919011039
- VindrieuxDEscobarPLazennecGEmerging roles of chemokines in prostate cancerEndocr Relat Cancer200916366367319556286
- MiyakeMLawtonAGoodisonSUrquidiVRosserCJChemokine (C-X-C motif) ligand 1 (CXCL1) protein expression is increased in high-grade prostate cancerPathol Res Pract20142102747824252309
- VadayGGPeehlDMKadamPALawrenceDMExpression of CCL5 (RANTES) and CCR5 in prostate cancerProstate200666212413416161154
- YangJWeiDLiuJRepressions of MMP-9 expression and NF-kappa B localization are involved in inhibition of lung carcinoma 95-D cell invasion by (−)-epigallocatechin-3-gallateBiomed Pharmacother20055939810315795102
- HastakKAgarwalMKMukhtarHAgarwalMLAblation of either p21 or Bax prevents p53-dependent apoptosis induced by green tea polyphenol epigallocatechin-3-gallateFASEB J200519778979115764647